Literature DB >> 20965535

Mice overexpressing the gene for heparin-binding epidermal growth factor-like growth factor (HB-EGF) have increased resistance to hemorrhagic shock and resuscitation.

Hong-yi Zhang1, Andrei Radulescu, Chun-liang Chen, Jacob K Olson, Amanda K Darbyshire, Gail E Besner.   

Abstract

BACKGROUND: The aim of the current study was to determine whether overexpression of heparin-binding epidermal growth factor-like growth factor (HB-EGF) could protect the intestines from injury after hemorrhagic shock and resuscitation in mice.
METHODS: Hemorrhagic shock and resuscitation was induced in HB-EGF transgenic and wild type mice. Cross-reacting material 197 (5 mg/kg) was administered to a subset of HB-EGF transgenic mice to block the overexpressed HB-EGF. Intestinal histologic injury scores, intestinal epithelial cell apoptosis indices, and gut barrier function were determined. The Student t test and 1-way analysis of variance were employed to compare the differences between groups.
RESULTS: All mice subjected to hemorrhagic shock and resuscitation had significantly increased intestinal histologic injury scores, apoptosis indices, and intestinal permeability compared with sham-operated mice. Compared with wild type mice, HB-EGF transgenic mice had significantly decreased histologic injury (mean injury grade 2.79 ± 0.84 vs 3.88 ± 1.43, P = .02), apoptosis indices (mean apoptosis index 8.77 ± 5.23 vs 17.91 ± 13.23, P = .03), and mucosal permeability (FITC-dextran 4 clearance 13.06 ± 5.67 vs 20.03 ± 7.81 nL/min/ m(2), P = .02) at 3 hours of reperfusion. HB-EGF transgenic mice subjected to hemorrhagic shock and resuscitation and treated with cross-reacting material 197 had a significantly increased histologic injury (mean injury grade 3.63 ± 1.00 vs 2.79 ± 0.84, P = .04) and mucosal permeability (FITC-dextran 4 clearance 22.87 ± 9.69 vs 13.06 ± 5.67 nL/min/cm2, P = .01) at 3 hours of reperfusion compared with non-cross-reacting material 197 treated transgenic mice, with no significant changes in apoptosis indices. Cross-reacting material 197 did not reverse the decreased apoptosis observed in HB-EGF transgenic mice subjected to hemorrhagic shock and resuscitation, which suggests that mechanisms in addition to decreased apoptosis may be responsible for the intestinal cytoprotective effects of endogenous HB-EGF overexpression.
CONCLUSION: Overexpression of HB-EGF increases resistance to hemorrhagic shock and resuscitation in mice. Copyright Â
© 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20965535      PMCID: PMC3022082          DOI: 10.1016/j.surg.2010.08.003

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  37 in total

1.  Heparin-binding epidermal growth factor-like growth factor overexpression in transgenic mice increases resistance to necrotizing enterocolitis.

Authors:  Andrei Radulescu; Hong-Yi Zhang; Xiaoyi Yu; Jacob K Olson; Amanda K Darbyshire; Yan Chen; Gail E Besner
Journal:  J Pediatr Surg       Date:  2010-10       Impact factor: 2.545

2.  Deletion of the heparin-binding epidermal growth factor-like growth factor gene increases susceptibility to necrotizing enterocolitis.

Authors:  Andrei Radulescu; Xiaoyi Yu; Nathan D Orvets; Yan Chen; Hong-Yi Zhang; Gail E Besner
Journal:  J Pediatr Surg       Date:  2010-04       Impact factor: 2.545

3.  Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase.

Authors:  L Liaudet; F G Soriano; E Szabó; L Virág; J G Mabley; A L Salzman; C Szabo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

4.  Heparin-binding epidermal growth factor-like growth factor protects rat intestine from ischemia/reperfusion injury.

Authors:  S B Pillai; C E Hinman; M H Luquette; P T Nowicki; G E Besner
Journal:  J Surg Res       Date:  1999-12       Impact factor: 2.192

5.  Intestinal phenotype in mice overexpressing a heparin-binding EGF-like growth factor transgene in enterocytes.

Authors:  Chun-Liang Chen; Veela B Mehta; Hong-Yi Zhang; Dana Wu; Iyore Otabor; Andrei Radulescu; Osama N El-Assal; Jiexiong Feng; Yan Chen; Gail E Besner
Journal:  Growth Factors       Date:  2010-04       Impact factor: 2.511

6.  Heparin-binding epidermal growth factor-like growth factor is essential for preservation of gut barrier function after hemorrhagic shock and resuscitation in mice.

Authors:  Hong-Yi Zhang; Andrei Radulescu; Gail E Besner
Journal:  Surgery       Date:  2009-08       Impact factor: 3.982

7.  HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.

Authors:  Veela B Mehta; Yu Zhou; Andrei Radulescu; Gail E Besner
Journal:  Growth Factors       Date:  2008-12       Impact factor: 2.511

Review 8.  Epithelial tight junctions in intestinal inflammation.

Authors:  Joerg D Schulzke; Svenja Ploeger; Maren Amasheh; Anja Fromm; Sebastian Zeissig; Hanno Troeger; Jan Richter; Christian Bojarski; Michael Schumann; Michael Fromm
Journal:  Ann N Y Acad Sci       Date:  2009-05       Impact factor: 5.691

9.  Heparin binding epidermal growth factor-like growth factor and PD169316 prevent apoptosis in mouse embryonic stem cells.

Authors:  Malini Krishnamoorthy; Jamie Heimburg-Molinaro; Ana M Bargo; Rachel J Nash; Rodney J Nash
Journal:  J Biochem       Date:  2008-11-14       Impact factor: 3.387

10.  Heparin-binding epidermal growth factor-like growth factor gene disruption is associated with delayed intestinal restitution, impaired angiogenesis, and poor survival after intestinal ischemia in mice.

Authors:  Osama N El-Assal; Heather Paddock; Alejandro Marquez; Gail E Besner
Journal:  J Pediatr Surg       Date:  2008-06       Impact factor: 2.545

View more
  6 in total

1.  Creating a flexible multiple microRNA expression vector by linking precursor microRNAs.

Authors:  Xiangning Qiu; Jeffrey M Friedman; Gangning Liang
Journal:  Biochem Biophys Res Commun       Date:  2011-06-24       Impact factor: 3.575

2.  Heparin-binding epidermal growth factor-like growth factor and mesenchymal stem cells act synergistically to prevent experimental necrotizing enterocolitis.

Authors:  Jixin Yang; Daniel Watkins; Chun-Liang Chen; Bharath Bhushan; Yu Zhou; Gail E Besner
Journal:  J Am Coll Surg       Date:  2012-07-21       Impact factor: 6.113

3.  Heparin-binding epidermal growth factor-like growth factor improves intestinal barrier function and reduces mortality in a murine model of peritonitis.

Authors:  Jixin Yang; Andrei Radulescu; Chun-Liang Chen; Hong-Yi Zhang; Iyore O James; Gail E Besner
Journal:  Surgery       Date:  2012-06-15       Impact factor: 3.982

4.  Heparin-binding EGF-like growth factor (HB-EGF) therapy for intestinal injury: Application and future prospects.

Authors:  Jixin Yang; Yanwei Su; Yu Zhou; Gail E Besner
Journal:  Pathophysiology       Date:  2013-12-15

5.  Heparin-binding EGF-like growth factor (HB-EGF) protects the intestines from radiation therapy-induced intestinal injury.

Authors:  Mika A B Matthews; Daniel Watkins; Amanda Darbyshire; William E Carson; Gail E Besner
Journal:  J Pediatr Surg       Date:  2013-06       Impact factor: 2.545

6.  HMGB1 neutralization is associated with bacterial translocation during acetaminophen hepatotoxicity.

Authors:  Runkuan Yang; Xiaoping Zou; Jyrki Tenhunen; Shengtao Zhu; Henri Kajander; Marja-Leena Koskinen; Tor Inge Tonnessen
Journal:  BMC Gastroenterol       Date:  2014-04-05       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.